China's Sinopharm says its Covid-19 vaccine is 79% effective

China’s state-owned pharmaceutical giant Sinopharm has announced its coronavirus vaccine is 79.34% effective.

Interim analysis of Phase 3 clinical trials show the vaccine is safe and people who received two doses produced high-level antibodies, according to a statement published by Beijing Biological Products Institute Co., a Sinopharm subsidiary.